Exactly.
In the small to mid cap Biotech space if you can find a company with a 24 to 36 month roadmap for commercialization...then you would expect $1 billion market cap minimum.
This will not be binary.
The market will rerate ANP as progress is made.
We won’t need to wait 24 months to reach $2...in fact if everything does go well, you would be expecting around the $4 to $5 range just for EMA market alone.
...and yes Akki, time will tell, it always does!
.
Where others have failed will Atl1102 succeed ?, page-74
-
- There are more pages in this discussion • 1,023 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
